نتائج البحث

Disease progression and defects in primary hemostasis as major cause of bleeding in multiple myeloma.

• Authors : Hinterleitner C; Department of Medical Oncology, Hematology, Immunology, Rheumatology and Pulmonology, Eberhard-Karls University, Tuebingen, Germany.; Pecher AC

Subjects: Blood Coagulation Disorders*/Blood Coagulation Disorders*/Blood Coagulation Disorders*/blood ; Blood Coagulation Disorders*/Blood Coagulation Disorders*/Blood Coagulation Disorders*/etiology ; Blood Coagulation Disorders*/Blood Coagulation Disorders*/Blood Coagulation Disorders*/mortality

• Source: European journal of haematology [Eur J Haematol] 2020 Jan; Vol. 104 (1), pp. 26-35. Date of Electronic Publication: 2019 Dec 05.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

Biological markers of hemostasis and endothelial activation in patients with a hematological malignancy with or without stem cell transplants.

• Authors : Buser TA; Department of Haematology, University Hospital Basel, Basel, Switzerland.; Martinez M

Subjects: Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/blood ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/pathology ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/therapy

• Source: European journal of haematology [Eur J Haematol] 2019 Nov; Vol. 103 (5), pp. 472-477. Date of Electronic Publication: 2019 Aug 27.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders.

• Authors : Olasupo, Omotola O.¹ (AUTHOR) ; Haddix, Craig² (AUTHOR); Nakar, Charles² (AUTHOR)

• Source: European Journal of Haematology. Mar2022, Vol. 108 Issue 3, p232-243. 12p.

تفاصيل العنوان

Biological markers of hemostasis and endothelial activation in patients with a hematological malignancy with or without stem cell transplants

• Authors : Dominik Heim; Beatrice Drexler; Maria Martinez

Subjects: Adult; Male; medicine.medical_specialty

• Source: European Journal of Haematology. 103:472-477

تفاصيل العنوان

Translation, validation, and usability of the International Society on Thrombosis and Haemostasis Bleeding Assessment Tool (Self‐ISTH‐BAT).

• Authors : Hansen, Rasmus Søgaard^1,2 (AUTHOR) ; Carlsen, Mette¹ (AUTHOR); Rasmussen, Kristina Fruerlund³ (AUTHOR)

• Source: European Journal of Haematology. Jul2021, Vol. 107 Issue 1, p104-110. 7p.

تفاصيل العنوان

Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo.

• Authors : von Känel, Roland; Dimsdale, Joel E.

• Source: European Journal of Haematology. Dec2000, Vol. 65 Issue 6, p357-369. 13p.

تفاصيل العنوان

Bacterial endotoxin as inhibitor of the enzymatic activity of human thrombin.

• Authors : Bucki, Robert^1,2 ; Pastore, Jennifer J.¹

• Source: European Journal of Haematology. Jun2006, Vol. 76 Issue 6, p510-515. 6p. 5 Graphs.

تفاصيل العنوان

Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo

• Authors : Roland von Känel; Joel E. Dimsdale

Subjects: medicine.medical_specialty; Sympathetic nervous system; business.industry

• Source: European Journal of Haematology. 65:357-369

تفاصيل العنوان

Desmopressin as a hemostatic and blood sparing agent in bleeding disorders.

• Authors : Mohinani A; Division of Internal Medicine, Oregon Health & Science University, Portland, Oregon, USA.; Patel S

Subjects: Hemostatics*/Hemostatics*/Hemostatics*/therapeutic use ; Hemostatics*/Hemostatics*/Hemostatics*/pharmacology ; von Willebrand Diseases*/von Willebrand Diseases*/von Willebrand Diseases*/complications

• Source: European journal of haematology [Eur J Haematol] 2023 May; Vol. 110 (5), pp. 470-479. Date of Electronic Publication: 2023 Feb 12.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

Assessment of joint bleeding and target joints in patients with severe or moderately severe hemophilia B (factor IX ≤2%) receiving prophylaxis with rIX-FP in the PROLONG-9FP clinical trial program.

• Authors : Laws HJ; Department of Paediatric Oncology, Haematology and Clinical Immunology, Centre for Child and Adolescent Health, University of Düsseldorf, Düsseldorf, Germany.; Fukutake K

Subjects: Hemophilia B*/Hemophilia B*/Hemophilia B*/complications ; Hemophilia B*/Hemophilia B*/Hemophilia B*/drug therapy ; Hemophilia A*/Hemophilia A*/Hemophilia A*/drug therapy

• Source: European journal of haematology [Eur J Haematol] 2023 Aug; Vol. 111 (2), pp. 293-299. Date of Electronic Publication: 2023 May 26.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان